Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dual GLP-1/glucagon receptor agonists derived from exendin-4

Dual GLP-1/glucagon receptor agonists derived from exendin-4

US Patent 9758561 · Granted Sep 12, 2017

Estimated economic value: $14,166,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymer nanoparticle compositions for in vivo expression of polypeptides2025
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and ste2022
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021
Selective glucagon receptor agonists comprising a chelating moiety for imaging p2021